Vaccine Conferences | USA | Global Events | Europe | Middle East | Asia Pacific | 2016 | 2017

Theme: To share the latest cutting-edge discoveries and emphasize current challenges in immunization

Vaccines usa 2016

Scientific Program (2016)

Vaccines usa 2016

ConferenceSeries Ltd organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ConferenceSeries Ltd is organizing 11^th Global Summit and Expo on Vaccines, Vaccination and Therapeutics. Vaccines conference in America slated at Phoenix, USA. During Sept 12-14, 2016. The theme of the conference is “To share the latest cutting-edge discoveries and emphasize current challenges in immunization”.

American Vaccines focused on the industry leaders and professionals of the Medical, Vaccine Research Development, Vaccine Business, Immunological Research and Vaccine Value Chain community, People focused on Immunoinformatics and Vaccines and Vaccine Informatics with the following profession areas: Innovators, Disruptors, and Influencers. Vaccines Business tripled in value from USD 5B in 2000 to almost USD 24 B in 2013, Global market projected to rise to USD 100 B by 2025. More than 120 new products in the development pipeline. 60 are of importance for developing countries. UNICEF had a market of 1,03 B$ in 2011, PAHO had 400 million dollars in 2011 and total UN market of 340 million dollars in 2002, 1,430 billion dollars in 2011 the vaccines business meetings will strengthen global network with the leaders.

Track 1: Vaccines Against Infectious Diseases and Cancers

The story of vaccines did not begin with the first vaccine–Edward Jenner’s use of material from cowpox (Chicken pox vaccines) pustules to provide protection against smallpox. Rather, it begins with the long history of infectious disease in humans, and in particular, with early uses of smallpox material to provide immunity to that disease. Methods for growing viruses in the laboratory led to rapid discoveries and innovations, including the creation of vaccines for polio. Measles, mumps, polio vaccines and rubella, Innovative techniques now drive vaccine research, with recombinant DNA technology and new delivery techniques leading scientists in new directions.

10^th Euro Global Summit and Expo on Vaccines & Vaccination June 16-18, 2016 Rome, Italy; 12th Asia Pacific Global Summit and Expo on Vaccines & Vaccination November 24-26, 2016 Melbourne, Australia; International Conference on Hepatitis Vaccines, September 26-28, 2016 Valencia, Spain; International Conference on Travel Medicine, Vaccines & Therapeutics August 01-02, 2016 New Orleans, USA; World Congress on Children Vaccines October 10-12, 2016 Kuala Lumpur, Malaysia; 14^th Annual Congress on Influenza Respiratory Diseases & Infections : Vaccines and Therapeutics; 15^th Annual Conference on HIV Vaccines & Therapeutics December 8-9, 2016 Philadelphia, USA; 10^th ISV Annual Vaccine congress 02-04 Oct 2016 Boston, USA; World Vaccines Congress Asia 03-04 June 2016 Singapore; Annual Pennsylvania Immunization Conference 16 June 2016 Pennsylvania; Immunization Summit 21-22 June 2016 Charleston; 10th Vaccine Congress 04-07 Sep Amsterdam, Netherlands.

Track 2: Cancer Vaccines

Cancer vaccines boost the immune system's natural ability to recognize and destroy things that are foreign and potentially harmful to the body. A strong, healthy immune system is able to identify antigens (substances on the surface of cells that are not normally part of the body) and attack them, typically eliminating them. The immune system is then left with a “memory” that helps it respond to those antigens in the future. A cancer treatment vaccine takes advantage of the immune system’s response to antigens. Often, cancer cells have specific molecules on their surface that are not present on healthy cells. When injected into a person, these specific molecules act as antigens, which stimulate the immune system to recognize and destroy cancer cells that have these molecules on their surface. Most cancer vaccines also contain Vaccine Adjuvants. Cancer vaccines are mainly for Preventive and prophylactic vaccines especially for cervical cancer Human Papilloma Virus Vaccine were used.

Track 3: Innate and Adaptive Immune Responses to Vaccination

Innate immune system and a specific adaptive immune system, the innate system responds non-specifically to live organisms, alerting the Adaptive Immunity system to respond rapidly and strongly with a specific immune response to the invading organism. Environmental proteins, outside of the context of a live invading organism, do not induce innate responses as they lack the signatures of a live organism that are typically recognized by components of the innate immune system. Without induction of the innate immune response, only a poor adaptive immune response is achieved. Therefore inactivated or protein subunit vaccines alone do not typically induce strong, broad or long-lasting adaptive immune responses leads to Autoimmunity

Track 4: HPV Vaccines

Vaccines and Cancer Vaccines Against infectious diseases represent a grave threat to animal and human populations in terms of their impact on global health, agriculture and the economy. Vaccines developed for emerging infections in animals can protect animal health and prevent transmission of zoonotic diseases to humans. The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations.

Track 5: Influenza and Flu Vaccines

Influenza is a serious disease that can lead to hospitalization and sometimes even death. Every flu season is different, and influenza infection can affect people differently. Even healthy people can get very sick from the flu and spread it to others. Flu vaccines cause antibodies to develop in the body about two weeks after vaccination. These antibodies provide protection against infection with the viruses that are in the vaccine. The seasonal flu vaccine protects against the influenza viruses that research indicates will be most common during the upcoming season. Traditional flu vaccines (called trivalent vaccines) are made to protect against three flu viruses; an influenza A (H1N1) virus, an influenza A (H3N2) virus, and an influenza B virus. In addition, there is Viral Immunology made to protect against four flu viruses (called “quadrivalent” vaccines). These vaccines protect against the same viruses as the trivalent vaccine and an additional B virus.

Track 6: Ebola Vaccines

Ebola haemorrhagic fever is a highly contagious disease that causes death in up to 90 percent of those infected with the virus. Furthermore, there is no treatment that will cure the infection once it begins; therefore, preventing the spread of the virus is crucial to containing outbreaks. This is one reason why research scientists are actively studying a possible Ebola vaccines. At this point, there is not a licensed vaccine for humans; however, an Ebola vaccine has shown to be effective in monkeys based on recent research findings, a single shot of a fast-acting, experimental vaccine successfully protected monkeys from the deadly Ebola virus after only one month. If this vaccine proves similarly effective in humans, it may one day allow scientists to quickly contain outbreaks with ring vaccination which is the same strategy that was successfully used against smallpox, This research has enormous public health implications, not only because it might be used to limit the spread of Ebola virus, which continues to emerge in central Africa, but also because this vaccine strategy may be applied to other highly lethal viruses that cause acute disease outbreaks and require a rapid response such as the Marburg and Lassa fever viruses, and the severe acute respiratory syndrome (SARS) coronavirus. In addition, there is Viral Immunology made to protect against Ebola Virus.

Track 7: Child vaccination & immunization /Pediatric Vaccines:

Vaccines not only help keep your child healthy, they help all children by stamping out serious childhood disorders. Vaccine Immunology had an enormous impact on improving the health of children. It is important that we continue to protect our children with vaccines because outbreaks of vaccine-preventable diseases by Childhood Vaccines like Chicken pox Vaccines etc. Vaccination is one of the best ways parents can protect infants, children, and teens from 16 potentially harmful diseases. Vaccine-preventable diseases can be very serious, may require hospitalization, or even be deadly – especially in infants and young children. Over 80% of the world's children are now being immunized against the polio vaccines, and the annual number of cases has been cut from 400,000 in 1980 to 90,000 in the mid-1990s. If the year 2000 goal of eradicating polio is achieved, the United States will be able to save the $270 million a year that is currently spent on polio vaccination. The savings for Western European countries will amount to about $200 million a year.

Track 8: Vaccines Discovery & Development

Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. Most of the vaccines in use today were developed in the 20th century. Here we collect a group of Vaccine Research Development, licensing events from our timelines to illustrate the extent of vaccine research that occurred in the wake of Louis Pasteur's development of the first laboratory-created vaccine in the late 1800s. Development of vaccines can be simplified into two broad stages: Pre-clinical development is research carried out in lab assays and on animals and Clinical research development is when the vaccine is first tested in humans.

Track 9: Veterinary Vaccine

The major goals of veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Vaccination for the animals diverse aims have led to different approaches to the development of veterinary vaccines from crude but effective whole-pathogen preparations to molecularly defined subunit vaccines, genetically engineered organisms or chimeras, vectored antigen formulations, and naked DNA injections. successful veterinary vaccines have been produced against viral immunology, bacterial, protozoa, and multicellular pathogens, which in many ways have led the field in the application and adaptation of novel technologies, These veterinary vaccines have had, and continue to have, a major impact not only on animal health and production but also on human health through increasing safe food supplies and preventing animal-to-human transmission of infectious diseases. The continued interaction between animals and human researchers and health professionals will be of major importance for adapting new technologies, providing animal models of disease, and confronting new and emerging infectious diseases.

Track 10: Vaccines Immunology

Vaccines Immunology (also called biologic therapy or biotherapy). Immunotherapy is treatment that uses certain parts of a person’s, enhancing, or suppressing immune system to fight diseases such as cancer, Tuberculosis. To enhance the immunity Childhood Vaccines like Chicken pox vaccines, Polio Vaccines were given for the children. The materials either made by the body or in a laboratory that restore immune system function. This can be done in two ways. Stimulating your own immune system to work better, faster or smarter to attack cancer cells. The therapies seek to treat diseases spanning oncology, respiratory medicine and allergy, dermatology, gastroenterology, hematology, infectious disease, neurobiology and nutrition. Immunotherapy also sometimes called biologic therapy or biotherapy. Active agents of immunotherapy are collectively called immune-modulators. Market Analysis: Global revenue for immunotherapy vaccines was nearly $28.8 billion in 2011.This market is expected for cancer vaccine to increase from $49.6 billion in 2020. In the case of USA $12.3billion in 2011, but it will increase half of the percentage by the end of 2017.

Track 11: Emerging Diseases

Emerging infectious diseases represent a grave threat to animal and human populations in terms of their impact on global health, agriculture and the economy. Vaccines developed for emerging infections in animals can protect animal health and prevent transmission of zoonotic diseases to humans. The vaccine technology market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization across the globe, increasing company investments in Vaccine Research Development, and rising initiatives by non-government organizations for vaccinations.

Track 12: HIV/AIDS Vaccines

Vaccines have been our best weapon against the world’s deadliest infectious diseases, including smallpox, polio, measles, and yellow fever. An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic. An HIV vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years.

Track 13: Recombinant vaccines

Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier. In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells. Recombinant Vector Vaccines closely mimic a natural infection and therefore do a good job of stimulating the immune system.

Track 14: Preventive vaccines

A preventative vaccination is carried out by introducing a part of the virus or an inactive virus into the body, the immune system reacts by producing antibodies. The virus enters the organism these antibodies will recognize and destroy it. Therapeutic response is administered to a person afflicted with a chronic viral infection, against which naturally produced antibodies are ineffective. In other words, therapeutic vaccines aim to increase the activity of the body’s natural defenses. Many vaccines companies focused on their Vaccine Research Development to enhance the productivity of preventive vaccines

Track 15: DNA vaccines

A DNA vaccine against a microbe would evoke a strong antibody response to the free-floating antigen secreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine couldn’t cause the disease because it wouldn’t contain the microbe, just copies of a few of its genes. The Immunological Research towards DNA vaccines are relatively easy and inexpensive to design and produce. DNA vaccines consist of DNA that is administered directly into the body. These vaccines can be administered with a needle and syringe or with a needle-less device that uses high-pressure gas to shoot microscopic gold particles coated with DNA directly into cells. Sometimes, the DNA is mixed with molecules that facilitate its uptake by the body’s cells. Naked DNA vaccines being tested in humans include those against the viruses that cause influenza and herpes.

Track 16: Diabetes Vaccines

Diabetes mellitus is a chronic degenerative disorder caused when the pancreas either fails to produce a protein hormone called insulin or the body's cells are resistant to the action of insulin. Without insulin, the body cannot process and use glucose, a blood sugar which is a chief source of energy for living organisms and is found in certain foods like fruit. If the body's cells have become resistant to insulin, glucose cannot be moved from the blood to cells in order to be transformed into energy. Whether Childhood Vaccines at birth will prevent Vaccine associated autoimmunity such as diabetes is not as clear as Classen's analysis of compelling data suggesting vaccines can be a co-factor in the development of Type I diabetes in children. Without large, well designed case controlled studies, his proposed solution to vaccinate at birth cannot be confirmed.

Track 17: Dental caries vaccine

Dental caries is an irreversible microbial disease of the calcified tissues of the teeth and it has a multifactorial origin. In India, the dental caries prevalence in 35-44 year olds was reported to be 80-95% in a DCI survey. Among the elderly in the 65-74 years age group, the DCI survey reported the caries prevalence to be about 70%, while the present survey reported it to be 51- 95% in various states. Surveys which were done on school children in India showed a caries prevalence of approximately 58%.Among the U.S. population, a survey showed an incidence of 93.8% in adults with either past or present coronal caries and an incidence of 45.3% in children 23. In countries like Brazil and China, it is reaching epidemic proportions. Thus, more effective public-health measures are needed to combat dental caries. Mutans Streptococci is one of the main microorganisms which are associated with the aetiology of dental caries. Preclinical studies of immunological interventions have shown that the disease can be interrupted. Clinical trials have indicated that a Mucosal Immune Responses to Streptococcus mutans crucial antigens can influence the pathogenesis of dental caries. The dental caries vaccine, when it is used in appropriate individuals at the appropriate time, can reduce the reem ergence of the disease.

Track 18: Vaccines Production / Manufacturing

Most vaccines are delivered via intramuscular or subcutaneous routes using a needle and syringe. There is currently Vaccine Research Development of new delivery systems for vaccines. The goal is to identify optimal methods for presenting target antigens to the immune system in a manner that will elicit immune responses appropriate for protection against, or treatment of, a specific disease. Several different approaches to this general goal have been developed, some are empirical and remain poorly understood, and others are more rational, being based, for example, on mimicking natural infections in vivo or on targeting particular features of the immune system. This article will review three categories of delivery systems: (i) adjuvants and formulations; (ii) antigen vectors, including live attenuated micro-organisms and synthetic vectors; and (iii) novel devices for vaccine administration.

Track 19: Delivery Technologies

Most vaccines are delivered via intramuscular or subcutaneous routes using a needle and syringe. Prominent market players of vaccines technology market are Bavarian Nordic (Denmark), CSL Limited (Australia), Emergent Bio Solutions Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson and Johnson (U.S.), MedImmune, LLC (U.S.), Merck and Company (U.S.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), and Sanofi Pasteur (France). Global Preventable Vaccines market to grow at a CAGR of 10.16 percent over the period 2014-2019. Major factors driving growth of vaccine technology market include rising prevalence of diseases, increasing government initiatives for expanding immunization techniques across the globe, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Topics related to Vaccine Research Development and vaccines safety will be covered by international speakers. This provides a forum for researchers, professionals and policy makers to present share and exchange the latest cutting edge discoveries in vaccines and vaccination. Vaccines manufacturing companies to facilitate new collaborations between experts in the field and inspire new and innovative ideas in the development of Vaccines and Vaccine Informatics

Track 20: Vaccines for Survival Diseases

Vaccination is an easy way to keep some serious illnesses at bay. While vaccines are best known for preventing diseases in childhood vaccines, immunizations can also protect adults and the elderly, too. Some of the vaccines for survival diseases are cutaneous conditions, Endocrine Diseases Vaccine, Eye Diseases and Disorders, Intestinal Diseases, Neurological Disorders.

Track 21: Viral Vaccines

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes. Viral vaccines contain either inactivated viruses or attenuated viruses. Inactivated or killed viral vaccines contain viruses, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live vaccines. Attenuated or live vaccines contain the live form of the virus. These viruses are not pathogenic but are able to induce an immune response. Some examples of viral vaccines are Ebola Vaccines, Polio Vaccines, and Human Papilloma Virus Vaccine.

Track 22: Novel Approaches in Design of Cellular and Molecular-Based Vaccines

HIV Vaccines Research Development are arguably the most powerful medical intervention in the fight against infectious diseases. The enormity of the global human immunodeficiency virus type 1 (HIV)/acquired immunodeficiency syndrome (AIDS) pandemic makes the development of an AIDS vaccine a scientific and humanitarian priority. Research on vaccines that induce T-cell immunity has dominated much of the recent development effort, mostly because of disappointing efforts to induce neutralizing antibodies through vaccination. Whereas T cells are known to limit HIV and other virus infections after infection, their role in protection against initial infection is much less clear. In this article, we will review the rationale behind a T-cell-based vaccine approach, provide an overview of the methods and platforms that are being applied, and discuss the impact of recent vaccine trial results on the future direction of T-cell vaccine research.

Track 23: Age-specific Immune Response to Vaccination

Vaccination in early infancy already forms part of the strategy to protect young infants against certain infectious diseases. (BCG, polio, HepB) More recently, the concept of maternal immunization has gained momentum and its role has already been established to prevent neonatal tetanus and more lately pertussis in some countries. Our understanding of the effect of vaccines on the maturation of immune function more generally and on interactions of vaccines between themselves more specifically is rudimentary to date, but lately, the concept of trained innate immunity has started to evolve. Over the last few years, a number of clinical trials have enrolled mothers and infants into vaccine studies. We are now in a position to assess the lessons learned from these and other ongoing international trials, to discuss current scientific progress in maternal and neonatal immunology, infections and immunizations, in the broader context of infectious disease epidemiology and public health.

Track 24: Vaccines Business Development

Vaccine Research Development comprises a number of tasks and processes generally aiming at developing and implementing growth opportunities within and between organizations. It is a subset of the fields of Vaccines business, commerce and organizational theory. Vaccines companies facilitate new collaborations between experts in the field and inspire new and innovative ideas in the development of Vaccines and Vaccine Informatics.

ConferenceSeries Ltd is Hearty invite the contributors across the globe to its premier 11th Global Summit and Expo on Vaccines, Vaccination and therapeutics, which is slated at Phoenix, USA. Sept 12-14, 2016

Vaccines 2016, is going to held at Phoenix, USA on September 12-14, 2016. Sign up today and attend all three days that make up this exclusive conference successful.

Vaccines 2016 conference aims to promote and share knowledge on current research & production of vaccines. The conference gathers Immunology specialists, Scientists, Professors and research faculty from academia, Clinical, Veterinary, Medical, CEO’s, Presidents, Policy makers, Professionals from regulatory agencies, Public health professionals, Business delegates of vaccines, Value Chain community of the vaccines with the following profession areas: Innovators, Disruptors, and Influencers, Post doc and PhD students in allied disciplines across the globe under a single roof gather in Phoenix to speak on current research and future strategies for development and production of vaccines.

ConferenceSeries Ltd gives the opportunity to hear the latest discoveries, current trends in Vaccines and Therapeutics from the global experts. The vaccines 2016 business meetings will strengthen global network with the leaders and Professionals.

Vaccines Business tripled in value from $5 Billion USD in 2000 to almost $24 Billion USD in 2013, Global market expected to rise to $100 Billion USD by 2025. More than 120 new products are in development pipeline from 60 developing countries.

UNICEF had a market of $1,03 Billion USD and PAHO had $400 million USD in 2011 and total value of vaccines in UN market of $340 million USD in 2002. The global therapeutic vaccines market was valued at $294 million USD.

Various pharmaceutical companies are developing novel vaccines for diseases such as breast cancer, lung cancer and Alzheimer, etc. Vaccines are becoming a key source for the pharmaceutical industry changing status of the vaccines within the pharma industry becoming new business model for vaccines. Newer and more expensive vaccines are coming into the market faster than ever before which leads to growing concentration in OECD countries but also newcomers.

Safety concerns associated with some vaccines like Pertussis Suggested as cause of severe neurological conditions, including permanent brain damage. The risk too small to be quantified, Polio Vaccine associated poliomyelitis, The risk estimated at 1-2 cases per million doses of vaccine and MMR Measles component may cause feverish convulsions in 1:1000 children ratio. Diphtheria Neurological reactions have been reported but the risk is too small to quantify. In general BCG vaccine severe injection site reactions occur usually associated with faulty vaccination technique, however overall estimated risk is less than 1 in 200,000 vaccinations.

Contact

Johann Cruyff

Email:americanvaccines@conferenceseries.net; americanvaccines@conferenceseries.com

http://vaccines.global-summit.com/america/

Continuing Medical Education (CME) Accreditation

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Professional Development (CPD) Accreditation

CPD accreditation and ConferenceSeries Ltd

The CPD Standards Office is a unique organisation founded with the vision of understanding and enabling positive and successful CPD learning experiences. As a highly specialised expert team, our university led research has equipped us with extensive expertise on all things CPD; including a thorough understanding of professional CPD and the use of CPD Certificates for formal CPD records. The Office seeks to encourage good educational processes, champion professional & personal development, and redefine and revitalise the image of CPD across sectors. This guide is an outline of how ConferenceSeries Ltd works with the CPD Standards Office to ensuring their training events are of the highest quality. ConferenceSeries Ltd and CPD Accreditation ConferenceSeries Ltd has successfully achieved CPD accreditation following a rigorous assessment process; the assessment and accreditation procedure has been developed following extensive research into CPD and best practice by the CPD Standards Office. The training events delivered by ConferenceSeries Ltd and accredited by the CPD Standards Office adhere to learning best practice, and as a result delegates can be issued formal CPD points and hours from attending the accredited CPD events. All event materials, content and internal processes have been assessed as part of the accreditation along with a review of ConferenceSeries Ltd’s marketing in this area, so delegates can are assured in the knowledge that the training events attended have been reviewed thoroughly and are being delivered to the highest standard.

11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics to be held during September 12-14, 2016 at Phoenix, USA with the theme “To share the latest cutting-edge discoveries and emphasize current challenges in immunization” Vaccines “With the exception of safe water, no other modality, not even antibiotics, has had such a major effect on mortality reduction…” Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, the global therapeutic vaccines market was valued at $294 million. This vaccine has expanded the horizon of chronic disease treatment. However, there is a need to get a vaccine for specific disease to be approved by the FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. Vaccines are becoming an engine for the pharmaceutical industry changing status of the vaccines within the pharmaceutical industry becoming a new business model for vaccines. Newer and more expensive vaccines are coming into the market faster than ever before and growing concentration in OECD countries but also newcomers.

Recent advances across a wide range of scientific disciplines have enhanced the prospects for developing new and better vaccines. These include the application of new technologies such as molecular biology to vaccine research, advances in our understanding of the immune system.

Safety concerns associated with some vaccines: Pertussis Suggested as cause of severe neurological conditions, including permanent brain damage. Risk too small to be quantified, Poliomyelitis Vaccine-associated poliomyelitis, Risk estimated at 1-2 cases per million doses of vaccine. MMR Measles component may cause feverish convulsions in 1 in 1000 children. Diphtheria Neurological reactions have been reported but risk is too small to quantify. BCG Severe injection site reactions occur usually associated with faulty vaccination technique. All Severe anaphylactic reactions are very rare. Overall risk estimated at less than 1 in 200,000 vaccinations.

The prospects in these areas as well as for the development of effective vaccines against globally significant diseases including:

-Vaccines that are heat-stable can be given orally, contain novel combinations, are suitable for use in infants shortly after birth, and protect against a wide range of diseases.

- New (sub-unit) vaccines against the most serious forms of malaria.

-Vaccines against HIV/AIDS, where scientists are trying to stimulate cell-mediated (e.g. killer T cell) responses to attack cells after they have become infected.

For more details please visit: http://vaccines.global-summit.com/america/

Importance of Vaccination

Vaccination belongs to important and effective ways of infectious diseases prevention. Along with securing of drinking water it belongs to the most effective ways of morbidity and mortality decreasing of infectious diseases in the world. That is why majority of countries in the world adopted in second half of the twentieth century immunization programs. Effectiveness of vaccination is unambiguously proven by regression up-to clearance of many diseases preventable by vaccination. Influence of vaccination can be best illustrated on eradication of smallpox in the world. Thanks to vaccination this deadly disease was overcome, in seventies of the last century this disease was the cause of many deaths. In countries with low immunization rate, i.e. with not adequate collective immunity, many vaccination preventable diseases occur.

Conference topics:

-Vaccines Against Infectious Diseases and Cancers

-Cancer Vaccines

-Vaccines Discovery & Development

-Innate and Adaptive Immune Responses to Vaccination

-HPV Vaccines

-Influenza and Flu Vaccines

-Ebola Vaccines

-Child vaccination & immunization / Pediatric Vaccines

-Veterinary Vaccines

-Vaccines Immunology

-Emerging Diseases

-HIV/AIDS Vaccines

-Recombinant vaccines

-Preventive vaccines

-DNA Vaccines

-Diabetes Vaccines

-Dental caries vaccine

-Vaccines Production / Manufacturing

-Delivery Technologies

-Vaccines for Survival Diseases

-Viral Vaccines

-Vaccinations Focusing on Induction of B or T cell Responses

-Novel Approaches in Design of Cellular and Molecular-Based Vaccines

-Vaccines against Viral Diseases

-Age-specific Immune Response to Vaccination

-Vaccines Business Development

Importance & Scope:

11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics main aim is to bring together leading academic scientists, researchers, business delegates, research scholars and student communities to exchange and share their experiences and research results about all aspects of vaccines, vaccination and therapeutics. It also provides the chance to present and discuss about the most recent trends in the innovation of new vaccines and their requirement. It is an international platform for the research about vaccines and the development of new vaccines, exchanging views about it and thus, contributes to the dissemination of knowledge in those fields.

About Phoenix

Vaccines 2016 is going to be held in Phoenix, USA. Phoenix the capital, and largest city of the state of Arizona with 1,445,632 people (as of the 2010 U.S. Census), Phoenix is the most populous state capital in the United States, as well as the sixth most populous city nationwide.

America’s sixth-largest city still has real cowboys and rugged mountains and the kind of cactus most people see only in cartoons. Phoenix is the gateway to the Grand Canyon, and its history is a testament to the spirit of puebloans, ranchers, miners and visionaries.

Golf courses that beckon players the year round. Shopping centres as stylish and eclectic as the fashions they house. It’s the No. 1 reason visitors come to Greater Phoenix. According to data compiled by the National Climatic Data Centre, Greater Phoenix basks in sunshine during 85 percent of the daylight hours - more often than any other major metropolitan area in the United States.

There are around 15 plus free, income based health clinics, public health department clinics, community health centers located in Phoenix. For the most part these clinics are for low income persons or those without insurance. And around 24 hospitals located in Phoenix offer the vaccination for the pediatric, geriatric, adolescent, pregnancy and elderly people.

Major Hospitals in Phoenix:

Mayo Clinic Hospital

St. Joseph's Hospital and Medical Center

Scottsdale Healthcare Shea Medical Center

Arizona Heart Hospital

Arizona Heart Institute

Banner Del E. Webb Medical Center

Barrow Neurological Institute

Chandler Regional Medical Center

Carl T. Hayden VA Medical Center

John C. Lincoln Deer Valley

John C. Lincoln North Mountain

Maricopa Medical Center

Mercy Gilbert Medical Center

Paradise Valley Hospital

Phoenix Baptist Hospital & Medical Center

Phoenix Children's Hospital

Phoenix Indian Medical Center

Phoenix Memorial Hospital

St. Luke's Medical Center

Valley Hospital

Major Hospitals in USA:

Massachusetts General Hospital, Boston

Mayo Clinic, Rochester, Minnesota

Johns Hopkins Hospital, Baltimore (Tie)

UCLA Medical Center, Los Angeles (Tie)

Cleveland Clinic

Brigham and Women's Hospital, Boston

New York-Presbyterian University Hospital of Columbia and Cornell, New York

UCSF Medical Center, San Francisco

Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia

Barnes-Jewish Hospital/Washington University, St. Louis

Northwestern Memorial Hospital, Chicago

NYU Langone Medical Center, New York

UPMC-University of Pittsburgh Medical Center

Duke University Hospital, Durham, North Carolina

Stanford Health-Stanford Hospital, Stanford, California

Major Hospitals around the World:

Johns Hopkins Hospital Baltimore U.S

Chris Hani Baragwanath Hospital Johannesburg South Africa

Stanford Hospitals and Clinics U.S

Great Ormond Street Hospital London UK

University of Texas MD Anderson Cancer Centre Houston U.S

Harvard Medical School Boston U.S

Karolinska Hospital, Stockholm, Sweden

The Priory UK

Bumrungrad International Hospital Bangkok Thailand

Cedars-Sinai Medical Center Los Angeles U.S

Major Universities in & Near Phoenix:

Arizona College of Medicine

The University of Arizona – The IMMUNOBIOLOGY College of Medicine

Major Universities in USA:

Harvard Medical School

UCSF School of Medicine

David Geffen School of Medicine

UNC School of Medicine

Pittsburgh School of Medicine

Stanford School of Medicine

Pritzker School of Medicine

Wash U School of Medicine in St. Louis

Mayo Medical School

UC San Diego School of Medicine

Weill Cornell Medical College

Vanderbilt School of Medicine

Baylor College of Medicine

University of Wisconsin School of Medicine

UT Southwestern Medical School

Columbia College of Physicians and Surgeons

Yale School of Medicine

UMASS School of Medicine

Boston University School of Medicine

Emory University School of Medicine

Maryland School of Medicine

Warren Alpert Medical School

Utah School of Medicine

Keck School of Medicine

UC Irvine School of Medicine

Vermont College of Medicine

Wake Forest University School of Medicine

University of Florida College of Medicine

Sidney Kimmel Medical College

University of Illinois College of Medicine

University of Cincinnati Academic Health Center

Tufts University School of Medicine

Virginia Commonwealth School of Medicine

Kentucky School of Medicine

Uniformed Services University of the Health Sciences

San Antonio School of Medicine

Temple School of Medicine

UT Houston School of Medicine

Rutgers New Jersey Medical School

Tennessee Health Science Center

Herbert Wertheim College of Medicine

Louisville School of Medicine

South Carolina School of Medicine

Penn State Hershey College of Medicine

Tulane University School of Medicine

The University of Texas Medical Branch at Galveston

Louisiana State University School of Medicine

Florida State University College of Medicine

Meharry School of Medicine

Lake Erie College of Osteopathic Medicine

Rutgers Robert Wood Johnson Medical School

Chicago College of Osteopathic Medicine

Edward VCOM Virginia Campus

UNECOM School of Osteopathic Medicine

Charles R. Drew University of Medicine and Science

Major Universities around the World:

Harvard University

University of Oxford

University of Cambridge

Johns Hopkins University

Stanford University

University of California, San Francisco

University of California, Los Angeles (UCLA)

Yale University

Karolinska Institutet

ULC London

Imperial College London

University of Pennsylvania

Duke University

University of Toronto

Columbia University

The University of Sydney

The University of Melbourne

University of Washington

The University of Tokyo

National University of Singapore (NUS)

Major Associations and Societies nearby Phoenix:

Allergy Asthma & Immunology Associates Ltd

Arizona allergy associates

Major Associations and Societies in USA:

National Cancer Institute

Advisory Committee on Immunization Practices (ACIP)

Advisory Commission on Childhood Vaccines

Vaccines and Related Biological Products Advisory Committee

American Pharmacists Association

American Medical Association

American Society for Microbiology Office of Education and Training

American Association for the Advancement of Science

Association for Women in Science

Sigma Xi, the Scientific Research Society

American Association for the Advancement of Science

American Association of Pharmaceutical Scientists

American Board of Toxicology

American College of Clinical Pharmacology

American Council on Pharmaceutical Education

Association of Clinical Research Professionals

Biotechnology Innovation Organization

American Society for Microbiology

Advanced Medical Technology Association

Association of Bio molecular Resource Facilities

American Academy of Allergy Asthma & Immunology

The American Association of Immunologists (AAI)

International union of microbiological societies (IUMS)

Argentine Association of Allergy and Immunology

Argentine Society of Allergy and Immunology

Brazilian Society of Allergy and Immunology

Chilean Society of Allergy and Immunology

Colombian Allergy, Asthma and Immunology Association

Cuban Society of Allergology

Ecuadorian Society of Allergy, Asthma, and Immunology

Guatemalan Allergy, Asthma and Clinical Immunology Association

Honduran Society of Allergy and Clinical Immunology

Mexican College of Allergy and Clinical Immunology (CMICA)

Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology

Panamanian Association of Allergology and Clinical Immunology

Paraguayan Society of Allergy, Asthma, and Immunology

Peruvian Society of Allergy and Immunology

Uruguayan Society of Allergology

Venezuelan Society of Allergy, Asthma and Immunology

American Academy of Allergy, Asthma and Immunology

American College of Allergy, Asthma and Immunology

Major Associations and Societies in Europe:

Albanian Society of Allergology and Clinical Immunology

Armenian Association of Immunology and Allergy

Austrian Society of Allergology and Immunology

Belarus Association of Allergology & Clinical Immunology

Belgian Society of Allergy and Clinical Immunology

British Society of Allergy and Clinical Immunology

Bulgarian National Society of Allergology

Croatian Society of Allergology and Clinical Immunology

Czech Society of Allergology and Clinical Immunology

Danish Society for Allergology

Dutch Society of Allergology

Finnish Society of Allergology and Clinical Immunology

French Society of Allergology and Clinical Immunology

Georgian Association of Allergology and Clinical Immunology

German Society for Allergology and Clinical Immunology

Hellenic Society of Allergology and Clinical Immunology

Hungarian Society of Allergology and Clinical Immunology

Icelandic Society of Allergy and Clinical Immunology

Italian Association of Territorial and Hospital Allergists

Italian Society of Allergy, Asthma and Clinical Immunology

Latvian Association of Allergists

Moldavian Society of Allergology & Immunology

Norwegian Society of Allergology and Immunopathology

Polish Society of Allergology

Portuguese Society of Allergology and Clinical Immunology

Romanian Society of Allergology and Clinical Immunology

Russian Association of Allergology and Clinical Immunology

Serbian Association of Allergologists and Clinical Immunologists

Slovenian Association for Allergology & Clinical Immunology

Spanish Society of Allergology and Clinical Immunology

Swedish Association for Allergology

Swiss Society of Allergology and Immunology

Ukrainian Allergists Association

Ukrainian Association of Allergologists and Clinical Immunologists

European Federation of Immunological societies (EFIS)

Major Associations and Societies in UK:

Microbiology Society

Association of British Healthcare Industries

Association for Clinical Data Management UK

Association of the British Pharmaceutical Industry

Major Associations and Societies in Asia-Pacific:

Allergy & Immunology Society of Sri Lanka

Allergy and Clinical Immunology Society (Singapore)

Allergy and Immunology Society of Thailand

Australasian Society of Clinical Immunology and Allergy

Bangladesh Society of Allergy and Immunology

Chinese Society of Allergology

Hong Kong Institute of Allergy

Indian Academy of Allergy

Indian College of Allergy, Asthma and Clinical Immunology

Indonesian Society of Allergy and Immunology

Japanese Society of Allergology

Korean Academy of Asthma, Allergy and Clinical Immunology

Malaysian Society of Allergy and Immunology

Mongolian Society of Allergology

Philippine Society of Allergy, Asthma and Immunology

Taiwan Academy of Pediatric Allergy Asthma Immunology

Vietnam Association of Allergy, Asthma and Clinical Immunology

Association of Biotechnology Led Enterprises (ABLE)

Biotechnology Industry Organization (BIO)

Association of Microbiologists of India

The Biotech Research Society

All India Biotech Association

Society for Applied Biotechnology

Indian Society of Genetics, Biotechnology Research

The Society for Biotechnologists

Biotechnology Society of India

The All India Crop Biotechnology Association

Society for Plant Biochemistry and Biotechnology

Major Associations and Societies in Africa/Middle-East:

Allergy Society of Kenya

Zimbabwe Allergy Society

Allergy Society of South Africa

Azerbaijan Society for Asthma, Allergy and Clinical Immunology

Egyptian Society of Allergy and Clinical Immunology

Egyptian Society of Pediatric Allergy and Immunology

Iranian Society of Asthma and Allergy

Israel Association of Allergy and Clinical Immunology

Jordanian Society for Allergy and Clinical Immunology

Kuwait Society of Allergy & Clinical Immunology

Lebanese Society of Allergy and Immunology

Moroccan Society of Allergology and Clinical Immunology

National Association for Private Algerian Allergists

Tunisian Society of Respiratory Diseases and Allergology

Turkish National Society of Allergy and Clinical Immunology

Major Associations / Societies and their Affiliate Organizations:

Canadian Society of Allergy and Clinical Immunology

British Society for Immunology

Global Allergy and Asthma European Network (GA2LEN)

International Association of Asthmology (INTERASMA)

International Primary Care Respiratory Group (IPCRG)

Southern European Allergy Societies (SEAS)

Dominican Society of Allergy, Asthma, and Immunology

Haitian Society of Allergy and Immunology

World Allergy Organization (WAO)

Major Associations / Societies and their Regional Organizations:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology

Asia Pacific Association of Pediatric Allergy, Respirology and Immunology

Commonwealth of Independent States Society of Allergology and Immunology

European Academy of Allergy and Clinical Immunology (EAACI)

Latin American Society of Allergy and Immunology

Top Companies in & near Phoenix:

GlaxoSmithKline – Phoenix, AZ

Merck & Co Inc. – Scottsdale, AZ

Top Companies in USA

InterveXion Therapeutics - Little Rock, AR

Novartis Diagnostics - Emeryville, CA

TM3 Therapeutics - Hayward, CA

Entest Biomedical – La Mesa, CA

Bavarian Nordic - Mountain View, CA

ImmunoScience - Pleasanton, CA

Juvaris - Pleasanton, CA

Tolerion - Portola Valley, CA

PaxVax - Redwood City, CA

Novartis - Vacaville, CA

Pfizer - South SF, CA

GeoVax - Atlanta, GA

Inhibikase Therapeutics - Atlanta, GA

Inhibikase Therapeutics - Cambridge, MA

Neon Therapeutics - Cambridge, MA

Xenetic Biosciences - Lexington, MA

Top Companies around the World:

Lipotek Acton - ACT, Australia

Admedus East Perth, WA, Australia

Gamma Vaccines Manuka, ACT, Australia

Sementis Melbourne, VIC, Australia

bioCSL (CSL) Parkville, VIC, Australia

Vaxxas Nanopatch Sydney, Australia

AFFiRiS Vienna, Austria

Sinovac Biotech - Beijing, China

GlaxoSmithKline - Shanghai, China

Sinovac Biotech - Tangshan, China

Vaxon Biotech - Paris, France

VitamFero - Tours, France

Bavarian Nordic - Planegg, Germany

Bharat Biotech - Hyderabad, India

Indian Immunologicals - Hyderabad, India

Shantha (Sanofi) - Hyderabad, India

Haffkine Biopharmaceuticals – Mumbai India

Panacea Biotec - New Delhi, India

MSD (Merck) - Carlow, Ireland

Pfizer - Clondalkin, Ireland

Crucell (Janssen Pharmaceutical) - Madrid, Spain

GlaxoSmithKline - Madrid, Spain

GlaxoSmithKline - Gloucestershire, UK

Antitope (Abzena) - Cambridge, UK

GlaxoSmithKline - Cumbria, UK

ImmBio - Cambridge, UK

GlaxoSmithKline - Harlow, UK

GlaxoSmithKline - Irvine, UK

Global Market Analysis of Vaccines

The global vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a growth rate of 11.8% from 2014 to 2019.

From global pharmaceutical market sale vaccines occupied very small size of market 2/3% but there is spectacular growth rate 10-15% per year when compare to pharmaceuticals which was 5-7% only. Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013.

Influenza vaccine market: estimated at $2.9 billion in 2011 to $3.8 billion by 2018 whereas US market: $1.6 billion in 2011 to $2.2 billion in 2018.

Global market projected to rise to USD 100 B by 2025; More than 120 new products in the development pipeline and 60 are of importance for developing countries

Wide licensing and registration of new and innovative vaccines Increased presence of sale forces and MNC representatives: "pharma like model.

Top 10 pharmaceutical companies based on global vaccine revenues in 2014 and 2020 (in million U.S. dollars)

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 12-14, 2016
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics September 12-14, 2016 Phoenix, Arizona, USA

Recommended Global Vaccines Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Vaccines usa 2016

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues

Conference Series LLC LTD Destinations

Conferences By Continents

Americas

Asia-Pacific & Middle East

Europe

Medical & Clinical Conferences

Conferences By Subject